{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:40:39Z","timestamp":1780929639422,"version":"3.54.1"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/100008891","name":"Loma Linda University","doi-asserted-by":"publisher","award":["2180166"],"award-info":[{"award-number":["2180166"]}],"id":[{"id":"10.13039\/100008891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,1,15]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Pediatric hypertension is currently one of the most common health concerns in children,\ngiven its effects not only on cardiovascular but also cognitive functions. There is accumulating evidence\nsuggesting neurocognitive dysfunction in hypertensive children that could persist even into\nadulthood. Identifying the precise mechanism(s) underlying the association between childhood hypertension\nand cognitive dysfunction is crucial as it could potentially lead to the discovery of \u201cdruggable\u201d\nbiological targets facilitating the development of treatments. Here, we discuss some of the proposed\npathophysiological mechanisms underlying childhood hypertension and cognitive deficits and suggest\nstrategies to address some of the current challenges in the field. The various research studies involving\nhypertensive adults indicate that long-term hypertension may produce abnormal cerebrovascular reactivity,\nchronic inflammation, autonomic dysfunction, or hyperinsulinemia and hypercholesterolemia,\nwhich could lead to alterations in the brain\u2019s structure and functions, resulting in cognitive dysfunction.\nIn light of the current literature, we propose that dysregulation of the hypothalamus-pituitaryadrenal\naxis, modifications in endothelial brain-derived neurotrophic factor and the gut microbiome\nmay also modulate cognitive functions in hypertensive individuals. Moreover, the above-mentioned\npathological states may further intensify the detrimental effects of hypertension on cognitive functions.\nThus, treatments that target not only hypertension but also its downstream effects may prove\nuseful in ameliorating hypertension-induced cognitive deficits.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title\/>\n<jats:p>Much remains to be clarified about the mechanisms and treatments of hypertension-induced cognitive\noutcomes in pediatric populations. Addressing the knowledge gaps in this field entails conducting not\nonly clinical research but also rigorous basic and translational studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527318666191017155442","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T06:33:10Z","timestamp":1572417190000},"page":"677-686","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Childhood Hypertension and Effects on Cognitive Functions: Mechanisms and Future Perspectives"],"prefix":"10.2174","volume":"18","author":[{"given":"Emma","family":"Tyner","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, Loma Linda University School of Pharmacy, Loma Linda, California, 92350, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Oropeza","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, Loma Linda University School of Pharmacy, Loma Linda, California, 92350, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Center for Health Disparities and Molecular Medicine, and Physiology Division, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, California 92350, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ike C. dela","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, Loma Linda University School of Pharmacy, Loma Linda, California, 92350, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.118.11673","volume":"73","author":"Bell C.S.","year":"2019","unstructured":"Bell C.S.; Samuel J.P.; Samuels J.A.; Prevalence of hypertension in children. Hypertension 2019,73(1),148-152","journal-title":"Hypertension"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1474-4422(10)70167-8","volume":"9","author":"Sharma M.","year":"2010","unstructured":"Sharma M.; Kupferman J.C.; Brosgol Y.; The effects of hypertension on the paediatric brain: A justifiable concern. Lancet Neurol 2010,9(9),933-940","journal-title":"Lancet Neurol"},{"key":"ref=3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1433","volume":"139","author":"Cheung E.L.","year":"2017","unstructured":"Cheung E.L.; Bell C.S.; Samuel J.P.; Poffenbarger T.; Redwine K.M.; Samuels J.A.; Race and obesity in adolescent hypertension. Pediatrics 2017,139(5)","journal-title":"Pediatrics"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apa.14551","volume":"108","author":"W\u00fchl E.","year":"2019","unstructured":"W\u00fchl E.; Hypertension in childhood obesity. Acta Paediatr 2019,108(1),37-43","journal-title":"Acta Paediatr"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-015-0608-3","volume":"18","author":"Brady T.M.","year":"2016","unstructured":"Brady T.M.; The role of obesity in the development of left ventricular hypertrophy among children and adolescents. Curr Hypertens Rep 2016,18(1),3","journal-title":"Curr Hypertens Rep"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpeds.2016.08.076","volume":"180","author":"Lande MB","year":"2017","unstructured":"Lande MB; Batisky DL; Kupferman JC; Neurocognitive function in children with primary hypertension.  J Pediatr  e1.2017,180,148-55","journal-title":"J Pediatr"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jash.2013.05.003","volume":"7","author":"Lande M.B.","year":"2013","unstructured":"Lande M.B.; Adams H.R.; Kupferman J.C.; Hooper S.R.; Szilagyi P.G.; Batisky D.L.; A multicenter study of neurocognition in children with hypertension: Methods, challenges, and solutions. J Am Soc Hypertens 2013,7(5),353-362","journal-title":"J Am Soc Hypertens"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fped.2018.00209","volume":"6","author":"Shatat I.F.","year":"2018","unstructured":"Shatat I.F.; Brady T.M.; Editorial: Pediatric hypertension: Update. Frontier Pediatr 2018,6,209","journal-title":"Frontier Pediatr"},{"key":"ref=9","first-page":"486","volume":"98","author":"Riley M.","year":"2018","unstructured":"Riley M.; Hernandez A.K.; Kuznia A.L.; High blood pressure in children and adolescents. Am Fam Physician 2018,98(8),486-494","journal-title":"Am Fam Physician"},{"key":"ref=10","first-page":"1","author":"Hales C.M.","year":"2017","unstructured":"Hales C.M.; Carroll M.D.; Fryar C.D.; Ogden C.L.; Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017(288),1-8","journal-title":"NCHS Data Brief"},{"key":"ref=11","volume":"138","author":"Rao G.","year":"2016","unstructured":"Rao G.; Diagnosis, epidemiology, and management of hypertension in children. Pediatrics 2016,138(2)","journal-title":"Pediatrics"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11906-013-0378-8","volume":"15","author":"Bucher B.S.","year":"2013","unstructured":"Bucher B.S.; Ferrarini A.; Weber N.; Bullo M.; Bianchetti M.G.; Simonetti G.D.; Primary hypertension in childhood. Curr Hypertens Rep 2013,15(5),444-452","journal-title":"Curr Hypertens Rep"},{"key":"ref=13","first-page":"133","volume":"9","author":"Re R.N.","year":"2009","unstructured":"Re R.N.; Obesity-related hypertension. Ochsner J 2009,9(3),133-136","journal-title":"Ochsner J"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/hr.2017.75","volume":"40","author":"Leggio M.","year":"2017","unstructured":"Leggio M.; Lombardi M.; Caldarone E.; The relationship between obesity and hypertension: An updated comprehensive overview on vicious twins. Hypertens Res 2017,40(12),947","journal-title":"Hypertens Res"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00467-009-1200-3","volume":"25","author":"Falkner B.","year":"2010","unstructured":"Falkner B.; Hypertension in children and adolescents: Epidemiology and natural history. Pediatr Nephrol 2010,25(7),1219-1224","journal-title":"Pediatr Nephrol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1751-7176.2011.00471.x","volume":"13","author":"Urbina E.M.","year":"2011","unstructured":"Urbina E.M.; Khoury P.R.; McCoy C.; Daniels S.R.; Kimball T.R.; Dolan L.M.; Cardiac and vascular consequences of prehypertension in youth. J Clin Hypertens 2011,13(5),332-342","journal-title":"J Clin Hypertens"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/HYPERTENSIONAHA.118.11686","volume":"73","author":"Lande M.B.","year":"2019","unstructured":"Lande M.B.; Kupferman J.C.; Blood pressure and cognitive function in children and adolescents. Hypertension 2019,73(3),532-540","journal-title":"Hypertension"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00467-012-2215-8","volume":"28","author":"Kupferman J.C.","year":"2013","unstructured":"Kupferman J.C.; Lande M.B.; Adams H.R.; Pavlakis S.G.; Primary hypertension and neurocognitive and executive functioning in school-age children. Pediatr Nephrol 2013,28(3),401-408","journal-title":"Pediatr Nephrol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1067\/S0022-3476(03)00412-8","volume":"143","author":"Lande M.B.","year":"2003","unstructured":"Lande M.B.; Kaczorowski J.M.; Auinger P.; Schwartz G.J.; Weitzman M.; Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr 2003,143(6),720-724","journal-title":"J Pediatr"},{"key":"ref=20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009847","volume":"7","author":"Lamballais S","year":"2018","unstructured":"Lamballais S; Sajjad A; Leening MJG;  Association of blood pressure and arterial stiffness with cognition in 2 population-based child and adult cohorts. J Am Heart Assoc e009847-e.2018,7(21)","journal-title":"J Am Heart Assoc"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1207\/s15324796abm3103_4","volume":"31","author":"Ditto B.","year":"2006","unstructured":"Ditto B.; S\u00e9guin J.R.; Tremblay R.E.; Neuropsychological characteristics of adolescent boys differing in risk for high blood pressure. Ann Behav Med 2006,31(3),231-237","journal-title":"Ann Behav Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/CIRCULATIONAHA.113.004798","volume":"129","author":"Yaffe K.","year":"2014","unstructured":"Yaffe K.; Vittinghoff E.; Pletcher M.J.; Early adult to midlife cardiovascular risk factors and cognitive function. Circulation 2014,129(15),1560-1567","journal-title":"Circulation"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.3949\/ccjm.82.s1.05","volume":"82","author":"Schulte E.E.","year":"2015","unstructured":"Schulte E.E.; Learning disorders: How pediatricians can help. Cleve Clin J Med 2015,82(11)(Suppl. 1),S24-S28","journal-title":"Cleve Clin J Med"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1542\/peds.2010-1899","volume":"126","author":"Adams H.R.","year":"2010","unstructured":"Adams H.R.; Szilagyi P.G.; Gebhardt L.; Lande M.B.; Learning and attention problems among children with pediatric primary hypertension. Pediatrics 2010,126(6),e1425-e9","journal-title":"Pediatrics"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00467-009-1205-y","volume":"24","author":"Krause I.","year":"2009","unstructured":"Krause I.; Cleper R.; Kovalski Y.; Sinai L.; Davidovits M.; Changes in behavior as an early symptom of renovascular hypertension in children. Pediatr Nephrol 2009,24(11),2271-2274","journal-title":"Pediatr Nephrol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fneur.2017.00685","volume":"8","author":"Figaji A.A.","year":"2017","unstructured":"Figaji A.A.; Anatomical and physiological differences between children and adults relevant to traumatic brain injury and the implications for clinical assessment and care. Front Neurol 2017,8,685","journal-title":"Front Neurol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-016-0774-5","volume":"14","author":"Shukla V.","year":"2017","unstructured":"Shukla V.; Shakya A.K.; Perez-Pinzon M.A.; Dave K.R.; Cerebral ischemic damage in diabetes: An inflammatory perspective. J Neuroinflamm 2017,14(1),21","journal-title":"J Neuroinflamm"},{"key":"ref=28","first-page":"1","volume":"3","author":"Gund B.","year":"2013","unstructured":"Gund B.; Jagtap P.; Ingale V.; Patil R.; Stroke: A brain attack. IOSR J Pharm 2013,3(8),1-23","journal-title":"IOSR J Pharm"},{"key":"ref=29","unstructured":"South Carolina Department of Health and Environmental Control; American Heart Association. What is high blood pressure? South Carolina State Documents Depository, 2017. Available at:"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.PSY.0000062531.75102.25","volume":"65","author":"Jennings J.R.","year":"2003","unstructured":"Jennings J.R.; Autoregulation of blood pressure and thought: Preliminary results of an application of brain imaging to psychosomatic medicine. Psychosom Med 2003,65(3),384-395","journal-title":"Psychosom Med"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1871527317666180219164545","volume":"17","author":"Balea M.","year":"2018","unstructured":"Balea M.; Muresanu D.; Alvarez A.; VaD - an integrated framework for cognitive rehabilitation. CNS Neurol Disord Drug Targets 2018,17(1),22-33","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=32","volume":"2012","author":"Cha S.D.","year":"2012","unstructured":"Cha S.D.; Patel H.P.; Hains D.S.; Mahan J.D.; The effects of hypertension on cognitive function in children and adolescents. Int J Pediatr 2012,2012","journal-title":"Int J Pediatr"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ndt\/gfl019","volume":"21","author":"Pauletto P.","year":"2006","unstructured":"Pauletto P.; Rattazzi M.; Inflammation and hypertension: The search for a link. Nephrol Dial Transplant 2006,21(4),850-853","journal-title":"Nephrol Dial Transplant"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3159283","volume":"2019","author":"Tanase D.M.","year":"2019","unstructured":"Tanase D.M.; Gosav E.M.; Radu S.; Arterial hypertension and interleukins: Potential therapeutic target or future diagnostic marker? Int J Hypertens 2019,2019,1-17","journal-title":"Int J Hypertens"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1590\/jvb.2014.054","volume":"13","author":"Teixeira B.C.","year":"2014","unstructured":"Teixeira B.C.; Lopes A.L.; Macedo R.C.O.; Inflammatory markers, endothelial function and cardiovascular risk. J Vasc Bras 2014,13(2),108-115","journal-title":"J Vasc Bras"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"Bautista L.","year":"2005","unstructured":"Bautista L.; Vera L.; Arenas I.; Gamarra G.; Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-\u03b1) and essential hypertension. J Hum hypertens 2005,19(2),149","journal-title":"J Hum hypertens"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.08.009","volume":"15","author":"Wright C.B.","year":"2006","unstructured":"Wright C.B.; Sacco R.L.; Rundek T.R.; Delman J.B.; Rabbani L.E.; Elkind M.S.; Interleukin-6 is associated with cognitive function: The Northern Manhattan study. J Stroke Cerebrovasc Dis 2006,15(1),34-38","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.psy.0000238451.22174.92","volume":"68","author":"Marsland A.L.","year":"2006","unstructured":"Marsland A.L.; Petersen K.L.; Sathanoori R.; Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 2006,68(6),895-903","journal-title":"Psychosom Med"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jintelligence5020019","volume":"5","author":"Sasayama D.","year":"2017","unstructured":"Sasayama D.; Kurahashi K.; Oda K.; Negative correlation between serum cytokine levels and cognitive abilities in children with autism spectrum disorder. J Intell 2017,5(2),19","journal-title":"J Intell"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2016.09.011","volume":"59","author":"Hennessy E.","year":"2017","unstructured":"Hennessy E.; Gormley S.; Lopez-Rodriguez A.B.; Murray C.; Murray C.; Cunningham C.; Systemic TNF-\u03b1 produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration. Brain Behav Immun 2017,59,233-244","journal-title":"Brain Behav Immun"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"Holmes C.","year":"2009","unstructured":"Holmes C.; Cunningham C.; Zotova E.; Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009,73(10),768-774","journal-title":"Neurology"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2008.01.025","volume":"153","author":"Lande M.B.","year":"2008","unstructured":"Lande M.B.; Meagher C.C.; Fisher S.G.; Belani P.; Wang H.; Rashid M.; Left ventricular mass index in children with white coat hypertension. J Pediatr 2008,153(1),50-54","journal-title":"J Pediatr"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/jhh.2013.111","volume":"28","author":"Hage F.","year":"2014","unstructured":"Hage F.; C-reactive protein and hypertension. J Hum Hypertens 2014,28(7),410","journal-title":"J Hum Hypertens"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000442585","volume":"6","author":"Watanabe Y.","year":"2016","unstructured":"Watanabe Y.; Kitamura K.; Nakamura K.; Elevated C-reactive protein is associated with cognitive decline in outpatients of a general hospital: The project in SADO for total health (PROST). Dement Geriatr Cogn Disord Extra 2016,6(1),10-19","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00125-017-4541-7","volume":"61","author":"Zheng F.","year":"2018","unstructured":"Zheng F.; Yan L.; Yang Z.; Zhong B.; Xie W.; HbA 1c, diabetes and cognitive decline: The English longitudinal study of ageing. Diabetologia 2018,61(4),839-848","journal-title":"Diabetologia"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archneurol.2009.308","volume":"67","author":"Noble J.M.","year":"2010","unstructured":"Noble J.M.; Manly J.J.; Schupf N.; Tang M.X.; Mayeux R.; Luchsinger J.A.; Association of C-reactive protein with cognitive impairment. Arch Neurol 2010,67(1),87-92","journal-title":"Arch Neurol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/gerona\/60.8.1017","volume":"60","author":"Ravaglia G.","year":"2005","unstructured":"Ravaglia G.; Forti P.; Maioli F.; Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci 2005,60(8),1017-1021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=48","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/120540","volume":"2012","author":"Eagan D.E.","year":"2012","unstructured":"Eagan D.E.; Gonzales M.M.; Tarumi T.; Tanaka H.; Stautberg S.; Haley A.P.; Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults. Cardiovasc Psychiatry and Neurol 2012,2012","journal-title":"Cardiovasc Psychiatry and Neurol"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2017.07.002","volume":"66","author":"Cullen A.E.","year":"2017","unstructured":"Cullen A.E.; Tappin B.M.; Zunszain P.A.; The relationship between salivary C-reactive protein and cognitive function in children aged 11\u201314 years: Does psychopathology have a moderating effect? Brain Behav Immun 2017,66,221-229","journal-title":"Brain Behav Immun"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","volume":"109","author":"Paul A.","year":"2004","unstructured":"Paul A.; Ko K.W.; Li L.; C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E\u2013deficient mice. Circulation 2004,109(5),647-655","journal-title":"Circulation"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.neubiorev.2006.07.001","volume":"30","author":"Raz N.","year":"2006","unstructured":"Raz N.; Rodrigue K.M.; Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci Biobehavioral Rev 2006,30(6),730-748","journal-title":"Neurosci Biobehavioral Rev"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1471-4159.2010.07168.x","volume":"116","author":"Russo I.","year":"2011","unstructured":"Russo I.; Barlati S.; Bosetti F.; Effects of neuroinflammation on the regenerative capacity of brain stem cells. J Neurochem 2011,116(6),947-956","journal-title":"J Neurochem"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","volume":"215","author":"Norlander A.E.","year":"2018","unstructured":"Norlander A.E.; Madhur M.S.; Harrison D.G.; The immunology of hypertension. J Exp Med 2018,215(1),21-33","journal-title":"J Exp Med"},{"key":"ref=54","volume":"2017","author":"Li D-P.","year":"2017","unstructured":"Li D-P.; Li Y-L.; Li J.; Wang S.; Neural mechanisms of autonomic dysfunction in neurological diseases. Neural Plast 2017,2017","journal-title":"Neural Plast"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1207\/s15324796abm2903_3","volume":"29","author":"Waldstein S.R.","year":"2005","unstructured":"Waldstein S.R.; Brown J.R.; Maier K.J.; Katzel L.I.; Diagnosis of hypertension and high blood pressure levels negatively affect cognitive function in older adults. Ann Behav Med 2005,29(3),174-180","journal-title":"Ann Behav Med"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1291\/hypres.24.19","volume":"24","author":"Kanemaru A.","year":"2001","unstructured":"Kanemaru A.; Kanemaru K.; KUWAJIMA I. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res 2001,24(1),19-24","journal-title":"Hypertens Res"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.STR.22.5.603","volume":"22","author":"Tohgi H.","year":"1991","unstructured":"Tohgi H.; Chiba K.; Kimura M.; Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. Stroke 1991,22(5),603-608","journal-title":"Stroke"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/archinte.1992.00400210081013","volume":"152","author":"Palatini P.","year":"1992","unstructured":"Palatini P.; Penzo M.; Racioppa A.; Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992,152(9),1855-1860","journal-title":"Arch Intern Med"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fnins.2019.00710","volume":"13","author":"Forte G.","year":"2019","unstructured":"Forte G.; Casagrande M.; Heart rate variability and cognitive function: A systematic review. Front Neurosci 2019,13,710","journal-title":"Front Neurosci"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/01.HYP.32.2.293","volume":"32","author":"Singh J.P.","year":"1998","unstructured":"Singh J.P.; Larson M.G.; Tsuji H.; Evans J.C.; O\u2019Donnell C.J.; Levy D.; Reduced heart rate variability and new-onset hypertension: Insights into pathogenesis of hypertension: The Framingham Heart Study. Hypertension 1998,32(2),293-297","journal-title":"Hypertension"},{"key":"ref=61","first-page":"37","volume":"23","author":"Xie G-L.","year":"2013","unstructured":"Xie G-L.; Wang J-h.; Zhou Y.; Xu H.; Sun J-H.; Yang S-R.; Association of high blood pressure with heart rate variability in children. Iranian J Pediatr 2013,23(1),37","journal-title":"Iranian J Pediatr"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neubiorev.2008.08.004","volume":"33","author":"Thayer J.F.","year":"2009","unstructured":"Thayer J.F.; Lane R.D.; Claude Bernard and the heart-brain connection: Further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev 2009,33(2),81-88","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amsu.2013.11.002","volume":"3","author":"Carthy E.R.","year":"2014","unstructured":"Carthy E.R.; Autonomic dysfunction in essential hypertension: A systematic review. Ann Med Surg 2014,3(1),2-7","journal-title":"Ann Med Surg"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.HYP.0000100444.71069.73","volume":"42","author":"Schroeder Emily B.","year":"2003","unstructured":"Schroeder Emily B.; Liao D.; Chambless Lloyd E.; Prineas Ronald J.; Evans Gregory W.; Heiss G.; Hypertension, blood pressure, and heart rate variability. Hypertension 2003,42(6),1106-1111","journal-title":"Hypertension"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/gerona\/gly061","volume":"74","author":"Suemoto C.K.","year":"2018","unstructured":"Suemoto C.K.; Baena C.P.; Mill J.G.; Santos I.S.; Lotufo P.A.; Bense\u00f1or I.; Orthostatic hypotension and cognitive function: Cross-sectional results from the ELSA-Brasil study. J Gerontol A Biol Sci Med Sci 2018,74(3),358-365","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/jnnp-2016-314123","volume":"87","author":"Udow S.J.","year":"2016","unstructured":"Udow S.J.; Robertson A.D.; MacIntosh B.J.; \u2018Under pressure\u2019: Is there a link between orthostatic hypotension and cognitive impairment in \u03b1-synucleinopathies? J Neurol Neurosurg Psychiatry 2016,87(12),1311-1321","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/01.HYP.22.5.771","volume":"22","author":"Kuusisto J.","year":"1993","unstructured":"Kuusisto J.; Koivisto K.; Mykk\u00e4nen L.; Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993,22(5),771-779","journal-title":"Hypertension"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"B228","DOI":"10.1093\/gerona\/55.5.B228","volume":"55","author":"Kumari M.","year":"2000","unstructured":"Kumari M.; Brunner E.; Fuhrer R.; Mini-Reviews: Mechanisms by which the metabolic syndrome and diabetes impair memory. J Gerontol A Biol Sci Med Sci 2000,55(5),B228-B32","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnagi.2013.00064","volume":"5","author":"Sato N.","year":"2013","unstructured":"Sato N.; Morishita R.; Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: Short-and long-term modification by non-genetic risk factors. Front Aging Neurosci 2013,5,64","journal-title":"Front Aging Neurosci"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"Prins N.D.","year":"2015","unstructured":"Prins N.D.; Scheltens P.; White matter hyperintensities, cognitive impairment and dementia: An update. Nat Rev Neurol 2015,11(3),157","journal-title":"Nat Rev Neurol"},{"key":"ref=71","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001140","volume":"4","author":"Wardlaw J.M.","year":"2015","unstructured":"Wardlaw J.M.; Vald\u00e9s Hern\u00e1ndez M.C.; Mu\u00f1oz\u2010Maniega S.; What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015,4(6)","journal-title":"J Am Heart Assoc"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11011-017-9980-9","volume":"32","author":"Hawkins K.A.","year":"2017","unstructured":"Hawkins K.A.; Emadi N.; Pearlson G.D.; Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients. Metab Brain Dis 2017,32(3),849-857","journal-title":"Metab Brain Dis"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbadis.2008.12.003","volume":"1792","author":"Roriz-Filho J.S.","year":"2009","unstructured":"Roriz-Filho J.S.; Sa-Roriz T.M.; Rosset I.; (Pre) diabetes, brain aging, and cognition. Biochim Biophys Acta Mol Basis Dis 2009,1792(5),432-443","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1871527317666180425122557","volume":"17","author":"Yaribeygi H.","year":"2018","unstructured":"Yaribeygi H.; Panahi Y.; Javadi B.; Sahebkar A.; The underlying role of oxidative stress in neurodegeneration: A mechanistic review. CNS Neurol Disord Drug Targets 2018,17(3),207-215","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.2040-1124.2012.00234.x","volume":"3","author":"Kawamura T.","year":"2012","unstructured":"Kawamura T.; Umemura T.; Hotta N.; Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? Journal of Diabetes Investigation 2012,3(5),413-423","journal-title":"Journal of Diabetes Investigation"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/187152731709180926121555","volume":"17","author":"Kumar A.","year":"2018","unstructured":"Kumar A.; Datusalia A.K.; Metabolic stress and inflammation: Implication in treatment for neurological disorders. CNS Neurol Disord Drug Targets 2018,17(9),642-643","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4239\/wjd.v7.i17.412","volume":"7","author":"Saedi E.","year":"2016","unstructured":"Saedi E.; Gheini M.R.; Faiz F.; Arami M.A.; Diabetes mellitus and cognitive impairments. World J Diabetes 2016,7(17),412","journal-title":"World J Diabetes"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/nmt.13.73","volume":"4","author":"Talbot K.","year":"2014","unstructured":"Talbot K.; Brain insulin resistance in Alzheimer\u2019s disease and its potential treatment with GLP-1 analogs. Neurodegener Dis Manag 2014,4(1),31-40","journal-title":"Neurodegener Dis Manag"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/WAD.0b013e318188e80d","volume":"22","author":"Goldstein F.C.","year":"2008","unstructured":"Goldstein F.C.; Ashley A.V.; Endeshaw Y.; Hanfelt J.; Lah J.J.; Levey A.I.; Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer\u2019s disease. Alzheimer Dis Assoc Disord 2008,22(4),336","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archneur.1993.00540020040015","volume":"50","author":"Desmond D.W.","year":"1993","unstructured":"Desmond D.W.; Tatemichi T.K.; Paik M.; Stern Y.; Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993,50(2),162-166","journal-title":"Arch Neurol"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-018-1199-0","volume":"10","author":"Tong X-K.","year":"2019","unstructured":"Tong X-K.; Trigiani L.J.; Hamel E.; High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: Benefits of simvastatin. Cell Death Dis 2019,10(2),89","journal-title":"Cell Death Dis"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-017-0167-y","volume":"12","author":"Ma C.","year":"2017","unstructured":"Ma C.; Yin Z.; Zhu P.; Luo J.; Shi X.; Gao X.; Blood cholesterol in late-life and cognitive decline: A longitudinal study of the Chinese elderly. Mol Neurodegener 2017,12(1),24","journal-title":"Mol Neurodegener"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"Herman J.","year":"2016","unstructured":"Herman J.; McKlveen J.; Ghosal S.; Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol 2016,6(2),603-621","journal-title":"Compr Physiol"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/REVNEURO.1999.10.2.117","volume":"10","author":"Lupien S.","year":"1999","unstructured":"Lupien S.; Nair N.; Briere S.; Increased cortisol levels and impaired cognition in human aging: Implication for depression and dementia in later life. Rev Neurosci 1999,10(2),117-140","journal-title":"Rev Neurosci"},{"key":"ref=85","first-page":"1949","volume":"87","author":"Bourdeau I.","year":"2002","unstructured":"Bourdeau I.; Bard Cl.; NoeQl B.; Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metabol 2002,87(5),1949-1954","journal-title":"J Clin Endocrinol Metabol"},{"key":"ref=86","first-page":"245","volume":"86","author":"Reynolds R.M.","year":"2001","unstructured":"Reynolds R.M.; Walker B.R.; Syddall H.E.; Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab 2001,86(1),245-250","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/ijms18102150","volume":"18","author":"Burford N.","year":"2017","unstructured":"Burford N.; Webster N.; Cruz-Topete D.; Hypothalamic-pituitary-adrenal axis modulation of glucocorticoids in the cardiovascular system. Int J Mol Sci 2017,18(10),2150","journal-title":"Int J Mol Sci"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1210\/jc.2004-2181","volume":"90","author":"Gold S.M.","year":"2005","unstructured":"Gold S.M.; Dziobek I.; Rogers K.; Bayoumy A.; McHugh P.F.; Convit A.; Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity. J Clin Endocrinol Metab 2005,90(6),3262-3267","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ACO.0000000000000032","volume":"27","author":"Riedel B.","year":"2014","unstructured":"Riedel B.; Browne K.; Silbert B.; Cerebral protection: Inflammation, endothelial dysfunction, and postoperative cognitive dysfunction. Curr Opin Anaesthesiol 2014,27(1),89-97","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0271678X18766772","volume":"38","author":"Marie C.","year":"2018","unstructured":"Marie C.; Pedard M.; Quirie A.; Brain-derived neurotrophic factor secreted by the cerebral endothelium: A new actor of brain function? J Cereb Blood Flow Metab 2018,38(6),935-949","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12035-014-8720-y","volume":"51","author":"Xu W.","year":"2015","unstructured":"Xu W.; Yu J.T.; Tan M.S.; Tan L.; Cognitive reserve and Alzheimer\u2019s disease. Mol Neurobiol 2015,51(1),187-208","journal-title":"Mol Neurobiol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.irn.2016.08.001","volume":"131","author":"Gareau M.","year":"2016","unstructured":"Gareau M.; Cognitive function and the microbiome. Int Rev Neurobiol 2016,131,227-246","journal-title":"Int Rev Neurobiol"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yclnex.2016.01.003","volume":"6","author":"Oriach C.S.","year":"2016","unstructured":"Oriach C.S.; Robertson R.C.; Stanton C.; Cryan J.F.; Dinan T.G.; Food for thought: The role of nutrition in the microbiota-gut-brain axis. Clin Nutr Exp 2016,6,25-38","journal-title":"Clin Nutr Exp"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fped.2017.00138","volume":"5","author":"Al Khodor S.","year":"2017","unstructured":"Al Khodor S.; Reichert B.; Shatat I.F.; The microbiome and blood pressure: Can microbes regulate our blood pressure? Front Pediatr 2017,5,138","journal-title":"Front Pediatr"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-016-9917-8","volume":"32","author":"Proctor C.","year":"2017","unstructured":"Proctor C.; Thiennimitr P.; Chattipakorn N.; Chattipakorn S.C.; Diet, gut microbiota and cognition. Metabolic Brain Dis 2017,32(1),1-17","journal-title":"Metabolic Brain Dis"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s11064-016-2039-1","volume":"41","author":"Maqsood R.","year":"2016","unstructured":"Maqsood R.; Stone T.W.; The gut-brain axis, BDNF, NMDA and CNS disorders. Neurochem Res 2016,41(11),2819-2835","journal-title":"Neurochem Res"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"Yang T.","year":"2015","unstructured":"Yang T.; Santisteban M.M.; Rodriguez V.; Gut dysbiosis is linked to hypertension. Hypertension 2015,65(6),1331-1340","journal-title":"Hypertension"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2017.00381","volume":"7","author":"Yan Q.","year":"2017","unstructured":"Yan Q.; Gu Y.; Li X.; Alterations of the Gut Microbiome in hypertension. Front Cell Infect Microb 2017,7,381","journal-title":"Front Cell Infect Microb"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.116.307709","volume":"118","author":"Santisteban M.M.","year":"2016","unstructured":"Santisteban M.M.; Kim S.; Pepine C.J.; Raizada M.K.; Brain-gut-bone marrow axis. Circulation research 2016,118(8),1327-1336","journal-title":"Circulation research"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.118.313792","volume":"123","author":"Jama H.","year":"2018","unstructured":"Jama H.; Kaye D.M.; Marques F.Z.; Population-based gut microbiome associations with hypertension: The need for more detailed phenotypes. Circ Res 2018,123(11),1185-1187","journal-title":"Circ Res"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2017.12.013","volume":"195","author":"Lande MB","year":"2018","unstructured":"Lande MB; Batisky DL; Kupferman JC; Neurocognitive function in children with primary hypertension after initiation of antihypertensive therapy. J Pediatr e12018,195,85-94","journal-title":"J Pediatr"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"Iadecola C.","year":"2016","unstructured":"Iadecola C.; Yaffe K.; Biller J.; Impact of hypertension on cognitive function: A scientific statement from the American Heart Association. Hypertension 2016,68(6),e67-e94","journal-title":"Hypertension"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1524-6175.2007.06639.x","volume":"9","author":"Asher J.","year":"2007","unstructured":"Asher J.; Houston M.; Statins and C-reactive protein levels. J Clin Hypertens 2007,9(8),622-628","journal-title":"J Clin Hypertens"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41440-018-0165-7","volume":"42","author":"Zhang H.","year":"2019","unstructured":"Zhang H.; Cui Y.; Zhao Y.; Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: A randomized, double-blind and placebo-controlled clinical trial. Hypertens Res 2019,42(5),717-729","journal-title":"Hypertens Res"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-018-0110-3","volume":"7","author":"Schultz B.G.","year":"2018","unstructured":"Schultz B.G.; Patten D.K.; Berlau D.J.; The role of statins in both cognitive impairment and protection against dementia: A tale of two mechanisms. Transl Neurodegener 2018,7,5","journal-title":"Transl Neurodegener"},{"key":"ref=106","first-page":"160","volume":"15","author":"Eiland L.S.","year":"2010","unstructured":"Eiland L.S.; Luttrell P.K.; Use of statins for dyslipidemia in the pediatric population. J Pediatr Pharmacol Ther 2010,15(3),160-172","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnins.2018.00215","volume":"12","author":"Benedict C.","year":"2018","unstructured":"Benedict C.; Grillo C.A.; Insulin resistance as a therapeutic target in the treatment of Alzheimer\u2019s disease: A state-of-the-art review. Front Neurosci 2018,12,215","journal-title":"Front Neurosci"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","volume":"63","author":"Yarchoan M.","year":"2014","unstructured":"Yarchoan M.; Arnold S.E.; Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 2014,63(7),2253-2261","journal-title":"Diabetes"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-160665","volume":"55","author":"Kennedy G.","year":"2017","unstructured":"Kennedy G.; Hardman R.J.; Macpherson H.; Scholey A.B.; Pipingas A.; How does exercise reduce the rate of age-associated cognitive decline? a review of potential mechanisms. J Alzheimers Dis 2017,55(1),1-18","journal-title":"J Alzheimers Dis"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11906-013-0390-z","volume":"15","author":"Bazzano L.A.","year":"2013","unstructured":"Bazzano L.A.; Green T.; Harrison T.N.; Reynolds K.; Dietary approaches to prevent hypertension. Curr Hypertens Rep 2013,15(6),694-702","journal-title":"Curr Hypertens Rep"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1871527317666180625104753","volume":"17","author":"Pandareesh M.D.","year":"2018","unstructured":"Pandareesh M.D.; Kandikattu H.K.; Razack S.; Nutrition and nutraceuticals in neuroinflammatory and brain metabolic stress: implications for neurodegenerative disorders. CNS Neurol Disord Drug Targets 2018,17(9),680-688","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=112","volume":"10","author":"Telle-Hansen V.H.","year":"2018","unstructured":"Telle-Hansen V.H.; Holven K.B.; Ulven S.M.; Impact of a healthy dietary pattern on gut microbiota and systemic inflammation in humans. Nutrients 2018,10(11)","journal-title":"Nutrients"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11906-017-0723-4","volume":"19","author":"Robles-Vera I.","year":"2017","unstructured":"Robles-Vera I.; Toral M.; Romero M.; Antihypertensive effects of probiotics. Curr Hypertens Rep 2017,19(4),26","journal-title":"Curr Hypertens Rep"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/175819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T08:59:41Z","timestamp":1582102781000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/175819\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,1,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527318666191017155442","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}